GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Ending Cash Position

ME Therapeutics Holding (XCNQ:METX) Ending Cash Position : C$1.35 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Ending Cash Position?

ME Therapeutics Holding's Ending Cash Position for the quarter that ended in Feb. 2024 was C$1.35 Mil.

ME Therapeutics Holding's quarterly Ending Cash Position declined from Aug. 2023 (C$0.65 Mil) to Nov. 2023 (C$0.38 Mil) but then increased from Nov. 2023 (C$0.38 Mil) to Feb. 2024 (C$1.35 Mil).

ME Therapeutics Holding's annual Ending Cash Position increased from . 20 (C$0.00 Mil) to Aug. 2022 (C$0.08 Mil) and increased from Aug. 2022 (C$0.08 Mil) to Aug. 2023 (C$0.65 Mil).

ME Therapeutics Holding Ending Cash Position Historical Data

The historical data trend for ME Therapeutics Holding's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Ending Cash Position Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Ending Cash Position
0.08 0.65

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Ending Cash Position Get a 7-Day Free Trial 0.50 0.63 0.65 0.38 1.35

ME Therapeutics Holding Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

ME Therapeutics Holding's Ending Cash Position for the fiscal year that ended in Aug. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.077+0.57
=0.65

ME Therapeutics Holding's Ending Cash Position for the quarter that ended in Feb. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.446+-0.099
=1.35

ME Therapeutics Holding Ending Cash Position Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Ending Cash Position
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines